Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Hemagen Diagnostics, Inc. (NasdaqSC:HMGN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Msgs | Insider
Location
9033 Red Branch Road
Colubia, MD 21045
Phone: (443) 367-5500
Email: info@hemagen.com
Employees (last reported count): 65
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 21%
·Institutional: 1% (1% of float)
(6 institutions)
·Net Inst. Selling: 1.73M shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Hemagen Diagnostics, Inc. develops, manufactures and markets proprietary medical diagnostic test kits (assays) used to aid in the diagnosis of autoimmune and infectious diseases, in general health assessment and for research purposes. Hemagen also develops, manufactures and markets materials for the manufacture of diagnostic test kits. Hemagen offers approximately 148 test kits that have been cleared by the FDA for sale in the United States. Hemagen markets and sells its brand name products worldwide, directly through its sales force and through national and international distributors. It markets its products in South America through its majority-owned subsidiary, Hemagen Diagnosticos Comercio, Importacao e Exportacao, Ltd., a Brazilian limited liability company. In addition, Hemagen sells certain of its products on a private-label basis to multinational distributors of medical diagnostic products.
More from Market Guide: Expanded Business Description

Financial Summary
Hemagen Diagnostics, Inc. is a biotechnology company which develops, manufactures and markets laboratory medical diagnostic kits used to aid in the diagnosis of certain autoimmune and infectious diseases. For the nine months ended 6/30/01, revenues rose 5% to $8.5 million. Net loss before acct. change fell 82% to $532 thousand. Revenues reflect increased sales at the Raichem division. Lower loss also benefitted from head count reductions and cost saving efforts.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

William Hales, 38
Pres
$150K--  
Deborah Ricci, 36
CFO, VP
76K--  
Ricardo De Oliveira, M.D., 49
VP of R&D
120K$1.2K
Dollar amounts are as of 30-Sep-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqSC:HMGNAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$0.375
Recent Price$0.95 
52-Week High
on 23-May-2001
$1.70 
Beta-0.66 
Daily Volume (3-month avg)33.0K
Daily Volume (10-day avg)13.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-29.3%
52-Week Change
relative to S&P500
-5.2%
Share-Related Items
Market Capitalization$9.32M
Shares Outstanding9.81M
Float7.70M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.55 
Earnings (ttm)-$0.21 
Earnings (mrq)-$0.01 
Sales (ttm)$1.06 
Cash (mrq)$0.11 
Valuation Ratios
Price/Book (mrq)1.74 
Price/EarningsN/A 
Price/Sales (ttm)0.90 
Income Statements
Sales (ttm)$11.4M
EBITDA (ttm)-$354.0K
Income available to common (ttm)-$2.69M
Profitability
Profit Margin (ttm)-23.5%
Operating Margin (ttm)-14.1%
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-26.13%
Return on Equity (ttm)-45.37%
Financial Strength
Current Ratio (mrq)2.84 
Debt/Equity (mrq)0.33 
Total Cash (mrq)$1.11M
Short Interest
As of 8-Aug-2001
Shares Short111.0K
Percent of Float1.4%
Shares Short
(Prior Month)
11.0K
Short Ratio4.62 
Daily Volume24.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.